The Risk Score for Statin Initiation
The primary risk score used to determine statin eligibility in the United States is the 10-year ASCVD (Atherosclerotic Cardiovascular Disease) risk calculator, also known as the Pooled Cohort Equation (PCE). 1
When to Calculate the Risk Score
You do NOT need to calculate a risk score in these situations—start statins directly:
- LDL-C ≥190 mg/dL (severe hypercholesterolemia): Begin high-intensity statin immediately 1
- Known ASCVD (secondary prevention): Statin indicated regardless of risk score
- Diabetes mellitus ages 40-75 with LDL-C ≥70 mg/dL: Start at least moderate-intensity statin without calculating risk 1
When Risk Calculation Matters (Ages 40-75, Primary Prevention)
For adults without diabetes and LDL-C 70-189 mg/dL, calculate the 10-year ASCVD risk:
Risk Thresholds:
- ≥20% risk: High risk—start high-intensity statin, reduce LDL-C by ≥50% 1
- ≥7.5% to <20% risk: Intermediate risk—start moderate-intensity statin after risk discussion, reduce LDL-C by ≥30% 1
- 5% to <7.5% risk: Borderline risk—consider statin only if risk-enhancing factors present 1
- <5% risk: Low risk—lifestyle modification, generally no statin
Risk-Enhancing Factors (For Intermediate/Borderline Risk)
These factors tip the decision toward statin therapy 1:
- Family history of premature ASCVD
- Persistently elevated LDL-C ≥160 mg/dL
- Metabolic syndrome
- Chronic kidney disease
- History of preeclampsia or premature menopause
- Chronic inflammatory disorders (rheumatoid arthritis, psoriasis, HIV)
- High-risk ethnicity (South Asian)
- Triglycerides ≥175 mg/dL persistently
- If measured: ApoB ≥130 mg/dL, hs-CRP ≥2.0 mg/L, ABI <0.9, Lp(a) ≥50 mg/dL
When Uncertainty Remains
If the decision is uncertain in intermediate-risk patients (7.5-19.9%), measure coronary artery calcium (CAC) 1:
- CAC = 0: May withhold statin (except smokers, diabetics, strong family history)
- CAC 1-99: Favors statin, especially age ≥55
- CAC ≥100 or ≥75th percentile: Statin indicated
Alternative Risk Scores
While the PCE is the U.S. standard, other regions use:
- QRISK2/QRISK3: Used in UK/NICE guidelines (≥10% 10-year risk threshold) 2, 3
- SCORE2: Used in Europe 4
- Framingham Risk Score: Older U.S. calculator, largely replaced by PCE 5, 6
Important caveat: Research shows these calculators can give substantially different risk estimates for the same patient 4. The PCE tends to overestimate risk in some populations, while QRISK may be more accurate in diverse ethnic groups 7. However, stick with the PCE for U.S. practice as it aligns with ACC/AHA guidelines 1.
Common Pitfalls
The evidence reveals significant undertreatment: Only 24% of young adults with prior ASCVD and 11-20% with LDL-C ≥190 mg/dL actually receive statins 8. When QRISK scores are documented, prescribing is 85% guideline-concordant, but when not documented, only 44% concordant—with clinicians inappropriately relying on total cholesterol alone 3. Always calculate and document the risk score to avoid these errors.